Valuation
- Market cap
- 9,000
- Revenue TTM
- $0
- Net income TTM
- $-4,470,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 1,700
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 87,350,000
- Stochastic %K
- —
- Beta
- -127.08
- Analysts
- —
- Price target
- —
Company profile
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area....
Show more
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 888 398 0202
- Website
- https://www.renovacareinc.com
- Address
- 9375 East Shea Blvd, Suite 107-A, Scottsdale, United States
Latest news
No headlines yet.
